As of 2024-12-12, the Fair Value of Prelude Therapeutics Inc (PRLD) is -11.95 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.94 USD, the upside of Prelude Therapeutics Inc is -1,371.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -27.57 | -56.93 | -111.69 | -115.44 | -121.83 | -86.69 |
| YoY growth | -87.81% | -106.49% | -96.19% | -3.36% | -5.54% | -59.88% |
| Market Cap (mil) | 51.74 |
| P/E | |
| Forward P/E |
| EPS | -2.39 |
| Avg earnings growth rate | -59.88% |
| TTM earnings | -131.52 |